The research progress of Tau protein

doi:10.3877/cma.j.issn.2095-9141.2016.02.012

Abstract

Abstract:

Tau protein is microtubule associated protein, not only express the central and peripheral nervous system, but also present in the lung, kidney and testis tissue. Tau protein in the central nervous system are mainly distributed in neuronal axons, participate in the assembly of microtubules and maintain the stability of microtubules. Abnormal accumulation of Tau protein is considered to be neuropathology sign of Alzheimer’s disease. In this paper, the function of the Tau protein made detailed reviews and related diseases.

Key words: Tau protein, Alzheimer’s disease, Nerve degeneration

Hongri Zhang, Jinghua Peng, Honglong Zhou, Ruxiang Xu. The research progress of Tau protein[J]. Chinese Journal of Neurotraumatic Surgery(Electronic Edition), 2016, 02(02): 108-111.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhsjcswkdzzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2095-9141.2016.02.012

https://zhsjcswkdzzz.cma-cmc.com.cn/EN/Y2016/V02/I02/108

References 33

[1]	Hirokawa N,Funakoshi T,Sato-Harada R, et al. Selective stabilization of tau in axons and microtubule-associated protein 2C in cell bodies and dendrites contributes to polarized localization of cytoskeletal proteins in mature neurons[J]. J Cell Biol, 1996, 132(4): 667-679.
[2]	Ittner LM,Ke YD,Delerue F, et al. Dendritic function of tau mediates amyloid-beta toxicity in Alzheimer’s disease mouse models[J]. Cell, 2010, 142(3): 387-397.
[3]	Zempel H,Luedtke J,Kumar Y, et al. Mandelkow E M Amyloid-β oligomers induce synaptic damage via Tau-dependent microtubule severing by TTLL6 and spastin[J]. EMBO J, 2013, 32(22): 2920-2937.
[4]	Hanger DP,Anderton BH,Noble W. Tau phosphorylation: The therapeutic challenge for neurodegenerative disease[J]. Trends Mol Med, 2009, 15(3): 112-119.
[5]	Santacruz K,Lewis J,Spires T, et al. Tau suppression in a neurodegenerative mouse model improves memory function[J]. Science, 2005, 309(5733): 476-481.
[6]	Andrews-Zwilling Y,Bien-Ly N,Xu Q, et al. Apolipoprotein E4 causes age-and tau-dependent impairment of GABAergic interneurons leading to learning and memory deficits in mice[J]. J Neurosci, 2010, 30(41): 13707-13717.
[7]	Jho YS,Zhulina EB,Kim MW, et al. Monte carlo simulations of tau proteins: Effect of phosphorylation[J]. Biophys J, 2010, 99(8): 2387-2397.
[8]	Fischer D,Mukrasch MD,Biernat J, et al. Conformational changes specific for pseudophosphorylation at serine 262 selectively impair binding of tau to microtubules[J]. Biochemistry, 2009, 48(42): 10047-10055.
[9]	Dolan PJ,Johnson GV. The role of tau kinases in Alzheimer’s disease [J]. Curr Opin Drug Discov Devel, 2010, 13(5): 595-603.
[10]	Wang QM,Fiol CJ,DePaoli-Roach AA, et al. Glycogen synthase kinase-3 beta is a dual specificity kinase differentially regulated by tyrosine and serine/threonine phosphorylation[J]. Biol Chem, 1994, 269(20): 14566-14574.
[11]	Dhavan R,Tsai LH. A decade of CDK5[J]. Nat Rev Mol Cell Biol, 2001, 2(10): 749-759.
[12]	Lee MS,Kwon YT,Li M, et al. Neurotoxicity induces cleavage of p35 to p25 by calpain[J]. Nature, 2000, 405(6784):360-364.
[13]	Vingtdeux V,Davies P,Dickson DW, et al. AMPK is abnormally activated in tangle-and pre-tangle-bearing neurons in Alzheimer disease and other tauopathies. Acta Neuropathol, 2011, 121(3): 337-349.
[14]	Gustke N,Steiner B,Mandelkow EM, et al.The Alzheimer-like phosphorylation of tau protein reduces microtubule binding and involves Ser-Pro and Thr-Pro motifs. FEBS Lett, 1992, 307(2): 199-205.
[15]	Majounie E,Cross W,Newsway V, et al. Variation in tau isoform expression in different brain regions and disease states[J]. Neurobiol Aging, 2013, 34(7): 1922.e7-1922.e12.
[16]	Ittner LM,Götz J. Amyloid-β and tau--A toxic pas de deux in Alzheimer’s disease[J]. Nat Rev Neurosci, 2011, 12(2):67-72.
[17]	Woehlke G,SchliwaM, Walking on two heads: the many talents of kinesin[J]. Nat. Rev Mol Cell Biol, 2000, 1(1): 50-58.
[18]	Toomre D,Manstein DJ. Lighting up the cell surface with evanescent wave microscopy[J]. Trends Cell Biol, 2001, 11(7): 298-303.
[19]	Ledesma MD,Medina M,Avila J. The in vitro formation of recombinant tau polymers: Effect of phosphorylation and glycation[J]. Mol Chem Neuropathol, 1996, 27(3): 249-258.
[20]	Hardy J,Selkoe DJ. The amyloid hypothesis of Alzheimer’s disease: Progress and problems on the road to therapeutics[J]. Science, 2002, 297(5580): 353-356.
[21]	Hamdane M,Dourlen P,Bretteville A, et al. Pin1 allows for differential Tau dephosphorylation in neuronal cells[J]. Mol Cell Neurosci, 2006, 32(1-2): 155-160.
[22]	Miyata Y,Koren J,Kiray J, et al. Molecular chaperones and regulation of tau quality control:strategies for drug discovery in tauopathies[J]. Future Med Chem, 2011, 3(12): 1523-1537.
[23]	Whiteman IT,Gervasio OL,Cullen KM, et al. Activated ADF/cofilin sequesters phosphorylated microtubuleassociated-protein during the assembly of Alzheimer-like neuritic cytoskeletal striations[J]. J Neurosci, 2009, 29(41): 129-134.
[24]	Hyman BT,Augustinack JC,Ingelsson M. Transcriptional and conformational changes of the tau molecule in Alzheimer’s disease[J]. Biochim Biophys Acta, 2005, 1739(2-3): 150-157.
[25]	Feuillette S,Miguel L,Frébourg T, et al. Drosophila models of human tauopathies indicate that Tau protein toxicity in vivo is mediated by soluble cytosolic phosphorylated forms of the protein[J]. J Neurochem, 2010, 113(4): 895-903.
[26]	Haase C,Stieler JT,Arendt T, et al. Pseudophosphorylation of tau protein alters its ability for self-aggregation[J]. Neurochem, 2004, 88(6): 1509-1520.
[27]	Stokin GB,Goldstein LS. Axonal transport and Alzheimer’s disease [J]. Annu Rev Biochem, 2006, 75: 607-627.
[28]	Reynolds CH,Betts JC,Blackstock WP, et al. Phosphorylation sites on tau identified by nanoelectrospray mass spectrometry: Differences in vitro between the mitogen-activated protein kinases ERK2 c-Jun N-terminal kinase and P38 and glycogen synthase kinase-3beta[J]. J Neurochem, 2000, 74(4): 1587-1595.
[29]	Mandelkow EM,Mandelkow E. Biochemistry and Cell Biology of Tau Protein in Neurofibrillary Degeneration[J]. Cold Spring Harb Perspect Med, 2012, 2(7): a006247.
[30]	Johnson GV,Stoothoff WH. Tau phosphorylation in neuronal cell function and dysfunction[J]. J Cell Sci, 2004, 117(Pt24): 5721-5729.
[31]	Spires-Jones TL,Stoothoff WH. Tau pathophysiology in neurodegeneration: A tangled issue[J]. Trends Neurosci, 2009, 32(3): 150-159.
[32]	Billingsley ML,Kincaid RL. Regulated phosphorylation and dephosphorylation of tau protein: Effects on microtubule interaction intracellular trafficking and neurodegeneration[J]. Biochem J, 2009, 16(Pt3): 409-427.
[33]	Zemlan FP,Rosenberg WS,Luebbe PA, et al. Quantification of axonal damage in traumatic brain injury: affinity purification and characterization of cerebrospinal fluid tau proteins[J]. J Neuro Chem, 1999, 72(2): 741-750.

Please choose a citation manager

Content to export